ADPT Valuation

Adaptive Biotechnologies Corp

Add to Watchlist

Advanced Chart

9.840

+2.480(+33.700%)

Overview
Forecast
Valuation

ADPT Relative Valuation

ADPT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ADPT is overvalued; if below, it's undervalued.

Historical Valuation

Adaptive Biotechnologies Corp (ADPT) is now in the Fair zone, suggesting that its current forward PS ratio of 5.13 is considered Fairly compared with the five-year average of 16.67. The fair price of Adaptive Biotechnologies Corp (ADPT) is between 7.01 to 10.07 according to relative valuation methord.

Relative Value

Fair Zone

7.01-10.07

Current Price：9.84

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

7.28

P/B

Median3y

2.73

Median5y

4.72

-9.04

FCF Yield

Median3y

-20.18

Median5y

-14.09

Competitors Valuation Multiple

The average P/S ratio for ADPT's competitors is 4.62, providing a benchmark for relative valuation. Adaptive Biotechnologies Corp Corp (ADPT) exhibits a P/S ratio of 5.13, which is 11.21% above the industry average. Given its robust revenue growth of 3.66%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

ADPT.O

Adaptive Biotechnologies Corp

5.13

Average P/S: 4.62

3.66%